Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2023

Open Access 01-12-2023 | Moxifloxacin | Case report

Keratitis following leech therapy for periocular eczematous dermatitis: a case report

Author: Dilek Özkaya

Published in: BMC Complementary Medicine and Therapies | Issue 1/2023

Login to get access

Abstract

Background

The medicinal leech therapy (MLT) is a kind of complementary treatment method used for various diseases. The leeches (Hirudo medicinalis) have been used for more than 2500 years by surgeons. The substances presenting in the saliva of leeches have anti-inflammatory, anticoagulant, platelet inhibitory, thrombin regulatory, analgesic, extracellular matrix degradative and antimicrobial effects. The method is cheap, easy to apply, effective and its mechanisms of action have been clarified for specific diseases. Infection particularly Aeromonas infection is the most common complication of MLT.

Case presentation

In this case report, a keratitis case developing after leech therapy applied for the periocular and facial eczematous dermatitis lesions will be presented. The patient referred to our hospital with decreased vision, ocular pain, stinging, redness and lacrimation complaints. A large corneal epithelial defect with irregular margins, dying by fluorescein, involving more than inferior half of cornea and conjunctival hyperemia were seen in the right eye. No agent was determined in microbiological investigation, as the patient had used topical moxifloxacin eye drop which was commenced in another clinic before applying to us. The patient was treated with fortified vancomycin and ceftazidime, before using besifloxacin with the diagnosis of bacterial keratitis. Three weeks later epithelial defect improved completely leaving an opacity and neovascularization.

Conclusions

MLT should be performed by certified physicians with sterile medicinal leeches and precautious antibiotics should be used before MLT for prevention against potential infections.
Literature
1.
go back to reference Abdullah S, Dar LM, Rashid A, Tewari A. Hirudotherapy /Leech therapy: Applications an Indications in Surgery. Arch Clin Exp Surg. 2012;1:172–80.CrossRef Abdullah S, Dar LM, Rashid A, Tewari A. Hirudotherapy /Leech therapy: Applications an Indications in Surgery. Arch Clin Exp Surg. 2012;1:172–80.CrossRef
2.
go back to reference Munshi Y, Ara I, Rafique H, Ahmad Z. Leeching in the history - a review. Pak J Biol Sci. 2008;11:1650–3.CrossRef Munshi Y, Ara I, Rafique H, Ahmad Z. Leeching in the history - a review. Pak J Biol Sci. 2008;11:1650–3.CrossRef
3.
go back to reference Sig AK, Guney M, Uskudar Guclu A, Ozmen E. Medicinal leech therapy-an overall perspective. Integr Med Res. 2017;6(4):337–43.CrossRef Sig AK, Guney M, Uskudar Guclu A, Ozmen E. Medicinal leech therapy-an overall perspective. Integr Med Res. 2017;6(4):337–43.CrossRef
4.
go back to reference Bauters TG, Buyle FM, Verschraegen G, Vermis K, Vogelaers D, Claeys G, et al. Infection risk related to the use of medicinal leeches. Pharm World Sci. 2007;29(3):122–5.CrossRef Bauters TG, Buyle FM, Verschraegen G, Vermis K, Vogelaers D, Claeys G, et al. Infection risk related to the use of medicinal leeches. Pharm World Sci. 2007;29(3):122–5.CrossRef
5.
go back to reference DelMonte DW, Kim T. Anatomy and physiology of the cornea. J Cataract Refract Surg. 2011;37:588–98.CrossRef DelMonte DW, Kim T. Anatomy and physiology of the cornea. J Cataract Refract Surg. 2011;37:588–98.CrossRef
6.
go back to reference Al-Debasi T, Al-Bekairy A, Al-Katheri A, Al Harbi S, Mansour M. Topical versus subconjunctival anti-vascular endothelial growth factor (Bevacizumab, Ranibizumab and Aflibercept) for treatment of corneal neovascularization. Saudi J Ophthalmol. 2017;31:99–105.CrossRef Al-Debasi T, Al-Bekairy A, Al-Katheri A, Al Harbi S, Mansour M. Topical versus subconjunctival anti-vascular endothelial growth factor (Bevacizumab, Ranibizumab and Aflibercept) for treatment of corneal neovascularization. Saudi J Ophthalmol. 2017;31:99–105.CrossRef
7.
go back to reference Keay L, Edwards K, Naduvilath T, Taylor HR, Snibson GR, Forde K, et al. Microbial keratitis predisposing factors and morbidity. Ophthalmology. 2006;113:109–16.CrossRef Keay L, Edwards K, Naduvilath T, Taylor HR, Snibson GR, Forde K, et al. Microbial keratitis predisposing factors and morbidity. Ophthalmology. 2006;113:109–16.CrossRef
8.
go back to reference Acharya M, Farooqui JH, Jain S, Mathur U. Pearls and paradigms in infective keratitis. Rom J Ophthalmol. 2019;63(2):119–27.CrossRef Acharya M, Farooqui JH, Jain S, Mathur U. Pearls and paradigms in infective keratitis. Rom J Ophthalmol. 2019;63(2):119–27.CrossRef
9.
go back to reference Ghods R, Abdi M, Pourrahimi M, Dabaghian FH. Leech therapy indications: a scoping review. Tradit Med Res. 2019;4:118–30.CrossRef Ghods R, Abdi M, Pourrahimi M, Dabaghian FH. Leech therapy indications: a scoping review. Tradit Med Res. 2019;4:118–30.CrossRef
10.
go back to reference Green PA, Shafritz AB. Medicinal leech use in microsurgery. J Hand Surg Am. 2010;35:1019–21.CrossRef Green PA, Shafritz AB. Medicinal leech use in microsurgery. J Hand Surg Am. 2010;35:1019–21.CrossRef
11.
go back to reference Maetz B, Abbou R, Andreoletti JB, Bruant-Rodier C. Infections following the application of leeches: two case reports and review of the literature. J Med Case Rep. 2012;6:364.CrossRef Maetz B, Abbou R, Andreoletti JB, Bruant-Rodier C. Infections following the application of leeches: two case reports and review of the literature. J Med Case Rep. 2012;6:364.CrossRef
12.
go back to reference Gülyesil FF, Sabaner MC, Duman R, Çetinkaya E, Duman. Periorbital cellulitis that developed after alternative medication of Hirudo Medicinalis application. J Clin Exp Ophthalmol. 2017;8:643. Gülyesil FF, Sabaner MC, Duman R, Çetinkaya E, Duman. Periorbital cellulitis that developed after alternative medication of Hirudo Medicinalis application. J Clin Exp Ophthalmol. 2017;8:643.
13.
go back to reference Kılıç M, Ak R. Orbital cellulitis due to leech therapy. Bull Emerg Trauma. 2019;7(3):335–6.CrossRef Kılıç M, Ak R. Orbital cellulitis due to leech therapy. Bull Emerg Trauma. 2019;7(3):335–6.CrossRef
Metadata
Title
Keratitis following leech therapy for periocular eczematous dermatitis: a case report
Author
Dilek Özkaya
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2023
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-022-03613-1

Other articles of this Issue 1/2023

BMC Complementary Medicine and Therapies 1/2023 Go to the issue